Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2050861747;61748;61749 chr2:178590203;178590202;178590201chr2:179454930;179454929;179454928
N2AB1886756824;56825;56826 chr2:178590203;178590202;178590201chr2:179454930;179454929;179454928
N2A1794054043;54044;54045 chr2:178590203;178590202;178590201chr2:179454930;179454929;179454928
N2B1144334552;34553;34554 chr2:178590203;178590202;178590201chr2:179454930;179454929;179454928
Novex-11156834927;34928;34929 chr2:178590203;178590202;178590201chr2:179454930;179454929;179454928
Novex-21163535128;35129;35130 chr2:178590203;178590202;178590201chr2:179454930;179454929;179454928
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: I
  • RefSeq wild type transcript codon: ATA
  • RefSeq wild type template codon: TAT
  • Domain: Ig-121
  • Domain position: 30
  • Structural Position: 46
  • Q(SASA): 0.2202
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
I/V None None 0.046 N 0.211 0.088 0.382925413656 gnomAD-4.0.0 4.80129E-06 None None None None I None 0 0 None 0 0 None 0 0 5.25001E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
I/A 0.704 likely_pathogenic 0.7623 pathogenic -2.17 Highly Destabilizing 0.825 D 0.739 prob.delet. None None None None I
I/C 0.7166 likely_pathogenic 0.742 pathogenic -1.428 Destabilizing 0.999 D 0.719 prob.delet. None None None None I
I/D 0.9741 likely_pathogenic 0.9836 pathogenic -1.682 Destabilizing 0.996 D 0.855 deleterious None None None None I
I/E 0.9409 likely_pathogenic 0.9585 pathogenic -1.597 Destabilizing 0.988 D 0.853 deleterious None None None None I
I/F 0.2677 likely_benign 0.2924 benign -1.466 Destabilizing 0.976 D 0.7 prob.neutral None None None None I
I/G 0.9318 likely_pathogenic 0.9547 pathogenic -2.583 Highly Destabilizing 0.988 D 0.84 deleterious None None None None I
I/H 0.8721 likely_pathogenic 0.9065 pathogenic -1.737 Destabilizing 0.999 D 0.829 deleterious None None None None I
I/K 0.8193 likely_pathogenic 0.859 pathogenic -1.571 Destabilizing 0.984 D 0.851 deleterious D 0.53148467 None None I
I/L 0.178 likely_benign 0.1898 benign -1.052 Destabilizing 0.211 N 0.458 neutral D 0.526099073 None None I
I/M 0.1563 likely_benign 0.1615 benign -0.872 Destabilizing 0.64 D 0.51 neutral D 0.53097769 None None I
I/N 0.7563 likely_pathogenic 0.8186 pathogenic -1.493 Destabilizing 0.996 D 0.85 deleterious None None None None I
I/P 0.9574 likely_pathogenic 0.9694 pathogenic -1.398 Destabilizing 0.996 D 0.852 deleterious None None None None I
I/Q 0.8618 likely_pathogenic 0.8941 pathogenic -1.559 Destabilizing 0.988 D 0.849 deleterious None None None None I
I/R 0.7668 likely_pathogenic 0.8241 pathogenic -1.05 Destabilizing 0.984 D 0.851 deleterious D 0.542840975 None None I
I/S 0.7269 likely_pathogenic 0.7983 pathogenic -2.173 Highly Destabilizing 0.988 D 0.839 deleterious None None None None I
I/T 0.5387 ambiguous 0.604 pathogenic -1.946 Destabilizing 0.896 D 0.771 deleterious N 0.510240089 None None I
I/V 0.0889 likely_benign 0.0839 benign -1.398 Destabilizing 0.046 N 0.211 neutral N 0.42563293 None None I
I/W 0.9149 likely_pathogenic 0.9237 pathogenic -1.569 Destabilizing 0.999 D 0.846 deleterious None None None None I
I/Y 0.7096 likely_pathogenic 0.7458 pathogenic -1.365 Destabilizing 0.988 D 0.737 prob.delet. None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.